Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Women Hold the Key to our Climate Future
Zainab Salbi, founder of Women for Women International and co-founder of Daughters for Earth, shares why she is putting women in positions of power to fight the climate crisis.
Load More